Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionoxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen

FMO4 CYP26B1 KDM4E TET1 KDM1B FTO CMAHP CYP4F11

4.06e-051941308GO:0016705
GeneOntologyMolecularFunction2,4-dienoyl-CoA reductase (NADPH) activity

PECR DECR1

1.26e-0431302GO:0008670
GeneOntologyMolecularFunctionepidermal growth factor receptor activity

ERBB4 EGFR

2.50e-0441302GO:0005006
GeneOntologyMolecularFunctiontranslation elongation factor activity

EEF1A1 EEF1A1P5 EEF1A2

2.83e-04201303GO:0003746
GeneOntologyMolecularFunctionamino acid:monoatomic cation antiporter activity

SLC38A5 SLC25A13

4.15e-0451302GO:0140848
GeneOntologyMolecularFunctionoxidoreductase activity

PECR FMO4 CYP26B1 COX15 RRM1 KDM4E NDUFB3 PGK1 DECR1 TET1 KDM1B FTO CMAHP CYP4F11

4.74e-0476613014GO:0016491
GeneOntologyBiologicalProcesscellular response to epidermal growth factor stimulus

ERBB2 ERBB4 EEF1A1 EGFR BAIAP2

1.35e-05491295GO:0071364
GeneOntologyBiologicalProcessresponse to epidermal growth factor

ERBB2 ERBB4 EEF1A1 EGFR BAIAP2

2.19e-05541295GO:0070849
GeneOntologyBiologicalProcesspositive regulation of kinase activity

ERBB2 RELN ERBB4 ANGPT1 ERN1 ALS2 TNFRSF10A CHRNA3 EEF1A2 TNFSF11 EGFR

4.89e-0540512911GO:0033674
GeneOntologyCellularComponentRAVE complex

DMXL2 DMXL1

1.16e-0431312GO:0043291
GeneOntologyCellularComponenteukaryotic translation elongation factor 1 complex

EEF1A1 EEF1A2

2.32e-0441312GO:0005853
DomainTyr_kinase_EGF/ERB/XmrK_rcpt

ERBB2 ERBB4 EGFR

1.19e-0641263IPR016245
DomainGF_recep_IV

ERBB2 ERBB4 EGFR

5.91e-0661263PF14843
DomainGF_recep_IV

ERBB2 ERBB4 EGFR

5.91e-0661263IPR032778
DomainRecep_L_domain

ERBB2 ERBB4 EGFR

1.03e-0571263PF01030
DomainFurin-like

ERBB2 ERBB4 EGFR

1.03e-0571263PF00757
DomainRcpt_L-dom

ERBB2 ERBB4 EGFR

1.03e-0571263IPR000494
DomainFurin-like_Cys-rich_dom

ERBB2 ERBB4 EGFR

1.03e-0571263IPR006211
Domain-

ERBB2 ERBB4 EGFR

1.03e-05712633.80.20.20
DomainTransl_elong_EF1A_euk/arc

EEF1A1 EEF1A2

4.52e-0521262IPR004539
DomainRav1p_C

DMXL2 DMXL1

4.52e-0521262IPR022033
DomainRav1p_C

DMXL2 DMXL1

4.52e-0521262PF12234
DomainNoelin-1

OLFM3 OLFM2

1.35e-0431262PF12308
DomainNoelin_dom

OLFM3 OLFM2

1.35e-0431262IPR022082
DomainFurin_repeat

ERBB2 ERBB4 EGFR

2.27e-04181263IPR006212
DomainFU

ERBB2 ERBB4 EGFR

2.27e-04181263SM00261
DomainRCC1

ALS2 RCC1 SERGEF

3.14e-04201263PF00415
DomainRCC1_1

ALS2 RCC1 SERGEF

3.65e-04211263PS00625
DomainRCC1_2

ALS2 RCC1 SERGEF

3.65e-04211263PS00626
DomainRCC1_3

ALS2 RCC1 SERGEF

3.65e-04211263PS50012
Domain-

ALS2 RCC1 SERGEF

4.20e-042212632.130.10.30
DomainReg_chr_condens

ALS2 RCC1 SERGEF

4.20e-04221263IPR000408
Domain-

SLC25A14 SLC25A30 SLC25A3 SLC25A13

4.48e-045312641.50.40.10
DomainMito_carr

SLC25A14 SLC25A30 SLC25A3 SLC25A13

4.48e-04531264PF00153
DomainSOLCAR

SLC25A14 SLC25A30 SLC25A3 SLC25A13

4.48e-04531264PS50920
DomainMitochondrial_sb/sol_carrier

SLC25A14 SLC25A30 SLC25A3 SLC25A13

4.48e-04531264IPR018108
DomainMt_carrier_dom

SLC25A14 SLC25A30 SLC25A3 SLC25A13

4.48e-04531264IPR023395
DomainRCC1/BLIP-II

ALS2 RCC1 SERGEF

4.81e-04231263IPR009091
DomainGphrmn_rcpt_fam

LGR4 LGR6

6.65e-0461262IPR002131
DomainTransl_B-barrel

RPL35A EEF1A1 EEF1A2

7.79e-04271263IPR009000
DomainTransl_elong_EFTu/EF1A_C

EEF1A1 EEF1A2

1.23e-0381262IPR004160
DomainGTP_EFTU_D3

EEF1A1 EEF1A2

1.23e-0381262PF03143
DomainG_TR_CS

EEF1A1 EEF1A2

1.58e-0391262IPR031157
DomainPkinase_Tyr

ERBB2 ERBB4 TEX14 ZAP70 EGFR

1.82e-031291265PF07714
DomainTransl_elong_EF1A/Init_IF2_C

EEF1A1 EEF1A2

1.96e-03101262IPR009001
DomainIL-1_rcpt_fam

IL1RAPL1 IL1RAPL2

2.39e-03111262IPR015621
DomainSer-Thr/Tyr_kinase_cat_dom

ERBB2 ERBB4 TEX14 ZAP70 EGFR

2.45e-031381265IPR001245
DomainMit_uncoupling

SLC25A14 SLC25A30

2.85e-03121262IPR002030
DomainTyr_kinase_cat_dom

ERBB2 ERBB4 ZAP70 EGFR

2.98e-03881264IPR020635
DomainTyrKc

ERBB2 ERBB4 ZAP70 EGFR

2.98e-03881264SM00219
DomainG_TR_1

EEF1A1 EEF1A2

3.35e-03131262PS00301
DomainOLF

OLFM3 OLFM2

3.35e-03131262PF02191
DomainOLF

OLFM3 OLFM2

3.35e-03131262PS51132
DomainOlfac-like_dom

OLFM3 OLFM2

3.35e-03131262IPR003112
DomainOLF

OLFM3 OLFM2

3.35e-03131262SM00284
DomainTF_fork_head_CS_2

FOXD4L1 FOXG1 FOXC2

3.68e-03461263IPR030456
DomainDynein_heavy_chain_D4_dom

DNAH3 DNAH7

3.90e-03141262IPR024317
DomainDynein_HC_stalk

DNAH3 DNAH7

3.90e-03141262IPR024743
DomainDynein_heavy_dom-2

DNAH3 DNAH7

3.90e-03141262IPR013602
DomainDHC_N2

DNAH3 DNAH7

3.90e-03141262PF08393
DomainMORN

ALS2 ANKMY1

3.90e-03141262SM00698
DomainMT

DNAH3 DNAH7

3.90e-03141262PF12777
DomainAAA_8

DNAH3 DNAH7

3.90e-03141262PF12780
DomainTF_fork_head_CS_1

FOXD4L1 FOXG1 FOXC2

3.92e-03471263IPR018122
DomainPROTEIN_KINASE_TYR

ERBB2 ERBB4 ZAP70 EGFR

4.22e-03971264PS00109
DomainTyr_kinase_AS

ERBB2 ERBB4 ZAP70 EGFR

4.22e-03971264IPR008266
DomainFH

FOXD4L1 FOXG1 FOXC2

4.41e-03491263SM00339
DomainFORK_HEAD_1

FOXD4L1 FOXG1 FOXC2

4.41e-03491263PS00657
DomainFORK_HEAD_2

FOXD4L1 FOXG1 FOXC2

4.41e-03491263PS00658
DomainFork_head_dom

FOXD4L1 FOXG1 FOXC2

4.41e-03491263IPR001766
DomainFORK_HEAD_3

FOXD4L1 FOXG1 FOXC2

4.41e-03491263PS50039
DomainForkhead

FOXD4L1 FOXG1 FOXC2

4.41e-03491263PF00250
DomainDHC_fam

DNAH3 DNAH7

4.48e-03151262IPR026983
DomainMORN

ALS2 ANKMY1

4.48e-03151262IPR003409
DomainDynein_heavy

DNAH3 DNAH7

4.48e-03151262PF03028
DomainMORN

ALS2 ANKMY1

4.48e-03151262PF02493
DomainDynein_heavy_dom

DNAH3 DNAH7

4.48e-03151262IPR004273
DomainEFTu-like_2

EEF1A1 EEF1A2

6.44e-03181262IPR004161
DomainGTP_EFTU_D2

EEF1A1 EEF1A2

6.44e-03181262PF03144
DomainG_TR_2

EEF1A1 EEF1A2

6.44e-03181262PS51722
PathwayREACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING

ERBB2 ERBB4 EGFR PRKCA

1.19e-0522934M26929
PathwayREACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING

ERBB2 ERBB4 EGFR

4.41e-0511933MM15478
PathwayWP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4

ERBB2 ERBB4 TNFSF11 EGFR

6.27e-0533934M39455
PathwayREACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING

ERBB2 ERBB4 EGFR

7.58e-0513933M27729
PathwayREACTOME_ERBB2_REGULATES_CELL_MOTILITY

ERBB2 ERBB4 EGFR

7.58e-0513933MM15320
PathwayREACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING

ERBB2 ERBB4 EGFR

9.60e-0514933MM14761
PathwayREACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING

ERBB2 ERBB4 EGFR

9.60e-0514933MM14531
PathwayPID_ERBB_NETWORK_PATHWAY

ERBB2 ERBB4 EGFR

1.19e-0415933M201
PathwayREACTOME_ERBB2_REGULATES_CELL_MOTILITY

ERBB2 ERBB4 EGFR

1.19e-0415933M27608
PathwayREACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING

ERBB2 ERBB4 EGFR

1.46e-0416933M562
PathwayREACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING

ERBB2 ERBB4 EGFR

1.46e-0416933M570
PathwayWP_ERBB_SIGNALING_PATHWAY

ERBB2 ERBB4 EGFR PRKCA

2.34e-0446934MM15950
PathwayREACTOME_SIGNALING_BY_ERBB2

ERBB2 ERBB4 EGFR PRKCA

3.24e-0450934M553
PathwayBIOCARTA_HER2_PATHWAY

ERBB2 ERBB4 EGFR

4.47e-0423933MM1480
PathwayBIOCARTA_HER2_PATHWAY

ERBB2 ERBB4 EGFR

4.47e-0423933M18719
Pubmed

Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma.

ERBB2 ERBB4 EGFR

5.34e-083132315026342
Pubmed

Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.

ERBB2 ERBB4 EGFR

5.34e-083132312532415
Pubmed

ErbB receptors protect the perfused heart against injury induced by epinephrine combined with low-flow ischemia.

ERBB2 ERBB4 EGFR

5.34e-083132319370475
Pubmed

Absence of EGFR, ERBB2 and ERBB4 mutation homologous to the oncogenic ERBB3 Val-104 mutation in colorectal cancers.

ERBB2 ERBB4 EGFR

5.34e-083132324862237
Pubmed

Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.

ERBB2 ERBB4 EGFR

5.34e-083132323100016
Pubmed

Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.

ERBB2 ERBB4 EGFR

5.34e-083132325468910
Pubmed

Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay.

ERBB2 ERBB4 EGFR

2.13e-074132324557338
Pubmed

Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.

ERBB2 ERBB4 EGFR

2.13e-074132323991224
Pubmed

Expression of epidermal growth factors, erbBs, in the nasal mucosa of patients with chronic hypertrophic rhinitis.

ERBB2 ERBB4 EGFR

2.13e-074132322327010
Pubmed

Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

ERBB2 ERBB4 EGFR

2.13e-074132317177598
Pubmed

The relevance of EGFR, ErbB receptors and neuregulins in human adipocytes and adipose tissue in obesity.

ERBB2 ERBB4 EGFR

2.13e-074132336411648
Pubmed

HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.

ERBB2 ERBB4 EGFR

2.13e-074132321203579
Pubmed

ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.

ERBB2 ERBB4 EGFR

2.13e-074132319263517
Pubmed

Analysis of ErbB receptors in pulmonary carcinoid tumors.

ERBB2 ERBB4 EGFR

2.13e-074132319447869
Pubmed

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

ERBB2 ERBB4 EGFR

2.13e-074132318985033
Pubmed

Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2.

ERBB2 ERBB4 EGFR

2.13e-07413239556621
Pubmed

Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours.

ERBB2 ERBB4 EGFR

2.13e-074132320204273
Pubmed

WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus.

ERBB2 ERBB4 EGFR

2.13e-074132312807903
Pubmed

HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.

ERBB2 ERBB4 EGFR

2.13e-074132327069134
Pubmed

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.

ERBB2 ERBB4 EGFR

2.13e-074132326021752
Pubmed

The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients.

ERBB2 ERBB4 EGFR

2.13e-074132316685269
Pubmed

The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.

ERBB2 ERBB4 EGFR

2.13e-074132315345710
Pubmed

Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.

ERBB2 ERBB4 EGFR

2.13e-074132312621152
Pubmed

Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy.

ERBB2 ERBB4 EGFR

2.13e-074132322854050
Pubmed

The erbB/HER type 1 tyrosine kinase receptor family.

ERBB2 ERBB4 EGFR

2.13e-07413239771475
Pubmed

Laminin-1 and epidermal growth factor family members co-stimulate fetal pancreas cell proliferation and colony formation.

ERBB2 ERBB4 EGFR

2.13e-074132315733067
Pubmed

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.

ERBB2 ERBB4 EGFR

2.13e-07413238816440
Pubmed

Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity.

ERBB2 ERBB4 EGFR

5.31e-075132310572067
Pubmed

Developmental profile of ErbB receptors in murine central nervous system: implications for functional interactions.

ERBB2 ERBB4 EGFR

5.31e-075132315682390
Pubmed

Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.

ERBB2 ERBB4 EGFR

5.31e-075132325416285
Pubmed

Tissue interaction mediated by neuregulin-1 and ErbB receptors regulates epithelial morphogenesis of mouse embryonic submandibular gland.

ERBB2 ERBB4 EGFR

5.31e-075132315254894
Pubmed

Expression of epidermal growth factors and a tight junction protein in the nasal mucosa of patients with chronic hypertrophic rhinitis.

ERBB2 ERBB4 EGFR

5.31e-075132323137868
Pubmed

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.

ERBB2 ERBB4 EGFR

5.31e-075132322554477
Pubmed

Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway.

ERBB2 ERBB4 EGFR

5.31e-075132315524405
Pubmed

Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.

ERBB2 ERBB4 EGFR

5.31e-075132312646923
Pubmed

Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.

ERBB2 ERBB4 EGFR

5.31e-075132326886748
Pubmed

Synapse-associated expression of an acetylcholine receptor-inducing protein, ARIA/heregulin, and its putative receptors, ErbB2 and ErbB3, in developing mammalian muscle.

ERBB2 ERBB4 EGFR

5.31e-07513237589796
Pubmed

Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.

ERBB2 EEF1A1 EEF1A1P5 EEF1A2 SLC25A3 YTHDF1 EGFR PRKCSH BAIAP2

6.36e-07256132924189400
Pubmed

Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice.

ERBB2 ERBB4 EGFR

1.06e-066132332335999
Pubmed

The ectodomain of cadherin-11 binds to erbB2 and stimulates Akt phosphorylation to promote cranial neural crest cell migration.

ERBB2 ERBB4 EGFR

1.06e-066132329190819
Pubmed

Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development.

ERBB2 ERBB4 EGFR

1.06e-066132315496447
Pubmed

LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.

ERBB2 ERBB4 EGFR

1.06e-066132315282549
Pubmed

Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.

ERBB2 ERBB4 EGFR

1.06e-066132311278868
Pubmed

Neuregulin-1/ErbB4 signaling controls the migration of oligodendrocyte precursor cells during development.

ERBB2 ERBB4 EGFR

1.85e-067132322504067
Pubmed

Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.

ERBB2 ERBB4 EGFR

1.85e-067132322493501
Pubmed

Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.

ERBB2 ERBB4 EGFR

1.85e-067132317487277
Pubmed

A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.

ERBB2 ERBB4 EGFR

1.85e-067132320446891
Pubmed

Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.

ERBB2 ERBB4 EGFR

1.85e-067132320126551
Pubmed

Neuregulin repellent signaling via ErbB4 restricts GABAergic interneurons to migratory paths from ganglionic eminence to cortical destinations.

RELN ERBB4 EGFR

2.95e-068132322376909
Pubmed

Differential expression of neuregulins and their receptors in the olfactory bulb layers of the developing mouse.

ERBB2 ERBB4 EGFR

2.95e-068132316488402
Pubmed

Dynamic expression of Erbb pathway members during early mammary gland morphogenesis.

ERBB2 ERBB4 EGFR

2.95e-068132317960183
Pubmed

Embryo-uterine interactions via the neuregulin family of growth factors during implantation in the mouse.

ERBB2 ERBB4 EGFR

2.95e-068132315306553
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

DMXL2 NHSL2 TRPC4 GRIA4 PPIB PGK1 EEF1A1 EEF1A2 NAV1 PRKCA MTCL1 BAIAP2 CAMSAP2 GOLGA1 FOXG1

4.10e-069631321528671696
Pubmed

ERBB3-dependent AKT and ERK pathways are essential for atrioventricular cushion development in mouse embryos.

ERBB2 ERBB4 EGFR

4.41e-069132334714866
Pubmed

Hepatic lipase maturation: a partial proteome of interacting factors.

PPIB EEF1A1 EEF1A2 SLC25A3

5.76e-0631132419136429
Pubmed

In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons.

ERBB2 ERBB4 EGFR

6.29e-0610132319298847
Pubmed

The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.

ERBB2 ERBB4 EGFR

6.29e-061013238702723
Pubmed

Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.

ERBB2 ERBB4 EGFR

6.29e-0610132320881644
Pubmed

Evidence for new homotypic and heterotypic interactions between transmembrane helices of proteins involved in receptor tyrosine kinase and neuropilin signaling.

ERBB2 ERBB4 EGFR

8.62e-0611132325315821
Pubmed

Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos.

ERBB2 ERBB4 EGFR

8.62e-0611132317822758
Pubmed

Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors.

ERBB2 ERBB4 EGFR

8.62e-0611132310821760
Pubmed

The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells.

ERBB2 ERBB4 ZAP70 EGFR PRKCA BAIAP2

1.29e-05134132624658140
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

SART3 DMXL2 RPL35A POLE COX15 RCC1 RRM1 PPIB DMXL1 AAR2 EEF1A2 CLCN7 EGFR NECTIN2 CNDP2 PRKCSH SCFD1 BAIAP2

1.38e-0514871321833957083
Pubmed

Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.

ERBB2 EGFR

1.43e-052132225349977
Pubmed

Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis.

ERBB2 EGFR

1.43e-052132223871709
Pubmed

Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report.

CHRNA3 EGFR

1.43e-052132220068085
Pubmed

HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.

ERBB2 EGFR

1.43e-052132223594562
Pubmed

Circulating Bone-related Markers and YKL-40 Versus HER2 and TOPO2a in Bone Metastatic and Nonmetastatic Breast Cancer: Diagnostic Implications.

ERBB2 TNFSF11

1.43e-052132228645722
Pubmed

FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells.

ERBB2 FTO

1.43e-052132235524932
Pubmed

Identification of autophosphorylation sites of HER2/neu.

ERBB2 EGFR

1.43e-05213221706616
Pubmed

Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.

ERBB2 EGFR

1.43e-052132219946741
Pubmed

EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation.

ERBB2 EGFR

1.43e-052132238416376
Pubmed

Evolutionary analysis of the ErbB receptor and ligand families.

ERBB2 EGFR

1.43e-052132210824084
Pubmed

Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.

ERBB2 ERBB4

1.43e-052132220022944
Pubmed

Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells.

ERBB2 EGFR

1.43e-052132225589492
Pubmed

Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study.

ERBB2 EGFR

1.43e-052132215143334
Pubmed

Protein kinase Calpha mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists.

EGFR PRKCA

1.43e-052132217307332
Pubmed

Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib.

ERBB2 EGFR

1.43e-052132218199554
Pubmed

Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium.

ERBB2 EGFR

1.43e-052132217549377
Pubmed

The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.

ERBB2 EGFR

1.43e-052132227502168
Pubmed

Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.

ERBB2 EGFR

1.43e-052132223665199
Pubmed

Epidermal growth factor receptor activity is necessary for mouse basal cell proliferation.

ERBB2 EGFR

1.43e-052132225217659
Pubmed

Continuous application of compressive force induces fusion of osteoclast-like RAW264.7 cells via upregulation of RANK and downregulation of LGR4.

LGR4 TNFSF11

1.43e-052132229572179
Pubmed

EGFR and HER2 expression in advanced biliary tract cancer.

ERBB2 EGFR

1.43e-052132219777609
Pubmed

Increased concentrations of growth factors and activation of the EGFR system in breast cancer.

ERBB2 EGFR

1.43e-052132223089711
Pubmed

EGFR Expression in HER2-Driven Breast Cancer Cells.

ERBB2 EGFR

1.43e-052132233260837
Pubmed

The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma.

ERBB2 EGFR

1.43e-052132234487971
Pubmed

Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.

ERBB2 EGFR

1.43e-052132218946768
Pubmed

Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis.

CD163 CD163L1

1.43e-052132211124526
Pubmed

Design, biological evaluation and 3D QSAR studies of novel dioxin-containing pyrazoline derivatives with thiourea skeleton as selective HER-2 inhibitors.

ERBB2 EGFR

1.43e-052132227273260
Pubmed

Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR.

ERBB2 EGFR

1.43e-052132212354693
Pubmed

Characterization of EGFR family gene aberrations in cholangiocarcinoma.

ERBB2 ERBB4

1.43e-052132224927194
Pubmed

Fluorescence-Raman dual modal endoscopic system for multiplexed molecular diagnostics.

ERBB2 EGFR

1.43e-052132225820115
Pubmed

Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.

ERBB2 EGFR

1.43e-052132223220854
Pubmed

A single ligand is sufficient to activate EGFR dimers.

ERBB2 ERBB4

1.43e-052132222699492
Pubmed

Gangliosides influence EGFR/ErbB2 heterodimer stability but they do not modify EGF-dependent ErbB2 phosphorylation.

ERBB2 EGFR

1.43e-052132220156584
Pubmed

EGFR and HER-2 oncogenes expression in an experimental model of two-stage chemically induced carcinogenesis in mouse skin.

ERBB2 EGFR

1.43e-052132238443188
Pubmed

Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer.

ERBB2 EGFR

1.43e-052132217611648
Pubmed

A novel dual EGFR/HER2 inhibitor KU004 induces cell cycle arrest and apoptosis in HER2-overexpressing cancer cells.

ERBB2 EGFR

1.43e-052132226437915
Pubmed

EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection.

ERBB2 EGFR

1.43e-052132222891338
InteractionNHERF1 interactions

ERBB2 TRPC4 RIPOR3 YTHDF1 EGFR CNDP2 PRKCA BAIAP2 FTO

2.60e-061831289int:NHERF1
InteractionNRG1 interactions

ERBB2 ERBB4 LGR4 TM2D3 GLOD4 EGFR TMEM181

5.11e-061061287int:NRG1
InteractionFER1L6 interactions

EEF1A1 EEF1A1P5 EEF1A2

8.60e-0671283int:FER1L6
InteractionTPT1 interactions

SART3 RPL35A ERN1 NHSL2 RFC1 PGK1 HDGFL3 EEF1A1 EEF1A2 PER2 EGFR

1.29e-0534512811int:TPT1
InteractionSLA2 interactions

ERBB2 ERBB4 ZAP70 EGFR

1.49e-05241284int:SLA2
InteractionSH2B3 interactions

ERBB2 ERBB4 ZAP70 EGFR

1.77e-05251284int:SH2B3
InteractionMUC4 interactions

ERBB2 ERBB4 EGFR

2.04e-0591283int:MUC4
InteractionMAGEA1 interactions

SPAG1 RNF166 MYO10 EEF1A1 EEF1A2 RCOR3

3.19e-05951286int:MAGEA1
InteractionSLA interactions

ERBB2 ERBB4 ZAP70 EGFR

3.26e-05291284int:SLA
InteractionPTPRT interactions

ERBB2 ERBB4 EGFR

3.98e-05111283int:PTPRT
InteractionLIPC interactions

PPIB EEF1A1 EEF1A2 SLC25A3

6.21e-05341284int:LIPC
GeneFamilyErb-b2 receptor tyrosine kinases

ERBB2 ERBB4 EGFR

4.00e-0748531096
GeneFamilySulfotransferases, cytosolic

SULT1B1 SULT1C3

1.92e-0314852762
GeneFamilyImmunoglobulin like domain containing

IL1RAPL1 IL1RAPL2 NECTIN2 CNTN3 IGSF3

2.16e-03193855594
GeneFamilyCD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing

IL1RAPL1 IL1RAPL2

2.20e-03158521296
GeneFamilyDyneins, axonemal

DNAH3 DNAH7

2.84e-0317852536
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ERBB4 ANGPT1 EGFR IL1RAPL2 NECTIN2 TMEM200C

1.17e-06181132703a303cd2f366f09c18b118bbba6f5e3f95ad56c
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPAG1 ERN1 ZAP70 TNFSF11 CD163L1 TMEM200C

1.34e-0517413266987fe7959afce347282f632abc16d800ccab7c4
ToppCelldroplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN SLC25A30 PKHD1L1 OVGP1 NECTIN2 FOXC2

2.02e-0518713269c9ae8725905ba0cfe407878006ed06c2480fb72
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ERBB4 ANGPT1 EGFR IL1RAPL2 TMEM200C

2.02e-051871326d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCelldroplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN SLC25A30 PKHD1L1 OVGP1 NECTIN2 FOXC2

2.02e-0518713269e9460e57cdc9cd0a0de2866b140e06d0bc19a8f
ToppCelldroplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN SLC25A30 PKHD1L1 OVGP1 NECTIN2 FOXC2

2.08e-051881326dc52dd2957be3f40001f0a56f3d9ac9d66ea466e
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RPL35A ZAP70 HDGFL3 EEF1A1 PRKCA CMAHP

2.08e-051881326467773d1e6b4828495a62f3b92996964d1c94b97
ToppCelldroplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN SLC25A30 PKHD1L1 OVGP1 NECTIN2 FOXC2

2.08e-0518813262ef08313087e91985bcffc46c3798470cdeec49c
ToppCelldroplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN SLC25A30 PKHD1L1 OVGP1 NECTIN2 FOXC2

2.08e-0518813261f1604b6dc0a8ad0be3d9aac0bef448459c22465
ToppCellcontrol-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

DMXL2 TEX14 CD163 SLC25A3 CNDP2 NAV1

2.14e-0518913267f78b5bb8195f99b18082cbb612e9199b7a1538c
ToppCelldroplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN ANKRD2 NECTIN2 TMEM200C IGSF3 FOXC2

2.27e-05191132651cff0594ac7ad8c065c8ea2301f8c149bd062b4
ToppCelldroplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN ANKRD2 NECTIN2 TMEM200C IGSF3 FOXC2

2.27e-051911326a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b
ToppCelldroplet-Lung-30m-Endothelial-lymphatic_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN ANKRD2 NECTIN2 TMEM200C IGSF3 FOXC2

2.27e-05191132638681a1b182d6af5cce85db5431b6eba4b20ad96
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ERBB4 ANGPT1 EGFR CD163L1 IGSF3

2.34e-0519213266a252e298f8a454623fa9c1c893a7a45a886d694
ToppCellCV-Severe-5|CV / Virus stimulation, Condition and Cluster

RPL35A RCC1 PGK1 EEF1A1 TNFSF11 PRKCA

2.41e-051931326d87fcd4553b6198c3128685b73ffd1b1ae88fbb5
ToppCellCV-Moderate-5|Moderate / Virus stimulation, Condition and Cluster

PSMA2 RCC1 PGK1 EEF1A1 TNFSF11 PRKCA

2.55e-051951326646d06ac3fa20acb172735c88cf45e01d212cebf
ToppCellcontrol-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PECR POLE ZAP70 RCOR3 OLFM2 LGR6

2.86e-0519913265db7c8089172ac8e796613b3cef618d87007a0ab
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron|3m / Sample Type, Dataset, Time_group, and Cell type.

ERBB4 RPL35A EEF1A1 IL1RAPL1 IL1RAPL2 CBLN2

2.94e-052001326a313b9a8bde1ea80a6eae183b76fba46b86558b4
ToppCellBrain_organoid-organoid_Tanaka_cellReport-1m-Macroglial-Astrocyte|1m / Sample Type, Dataset, Time_group, and Cell type.

RPL35A MYO10 RBP4 EEF1A1 DECR1 OLFM3

2.94e-0520013264a6efb1b756995d217aacc38639c1bd40f1fd725
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic

RELN ERBB4 ANGPT1 EGFR IL1RAPL2 TMEM200C

2.94e-0520013268a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1
ToppCellPND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DMXL2 RIPOR3 EEF1A1 TNFSF11 CD163L1

6.12e-05140132511e441c3435ad8911ab401ca7d4ae1d3e5fa6eac
ToppCellPND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DMXL2 RIPOR3 EEF1A1 TNFSF11 CD163L1

6.12e-05140132594444b92acfad64d811ebb1545dc1dab64473795
ToppCellCOVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

CNBD1 RELN KDM4E IL1RAPL1 TEX46

7.46e-051461325c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARL9 PPIB ALG1L2 EEF1A1 FOXC2

7.71e-051471325f703cb0330304799d16e457215269c7732c9d5d5
ToppCellsevere_COVID-19-MAIT|World / disease group, cell group and cell class (v2)

ERN1 MAFA ANKMY1 SCMH1 KCNQ3

9.60e-05154132565ec7f7ef05c589903c4c9fe3849478c325fdc61
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 CHRNA3 EGFR CBLN2 IGSF3

9.89e-0515513253b8def9e8f66511736ea37f259511f7c8b7743af
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

CHRNA3 GLCE KCNQ3 MTCL1 FOXG1

1.02e-0415613257e6805ebc7bc2f9c5965321d16922c155719970f
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

CHRNA3 GLCE KCNQ3 MTCL1 FOXG1

1.02e-041561325741de05295b2d012ac8576378f37709a97c8fb50
ToppCellsevere_COVID-19-MAIT|severe_COVID-19 / disease group, cell group and cell class (v2)

ERN1 MAFA ANKMY1 SCMH1 KCNQ3

1.05e-041571325175f637e9707836bd63b5c2ccc9d4eb601c05b9e
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

CNBD1 DNAH3 RELN IL1RAPL1 XIRP2

1.12e-0415913255335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADAD1 ZAP70 TNFSF11 CD163L1 CMAHP

1.12e-0415913258d958d79f5eb3ab683d1245ae7f4f22a2cefbc55
ToppCell3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LHFPL1 KCNC4 CNTN3 PAX1 ZNF44

1.12e-0415913251baf0eaf9684668146a63192e77eec6c3c7a37f8
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 ANGPT1 CHRNA3 EGFR IGSF3

1.18e-0416113253b5d7a3dab479c6959a428f3954dedd989900276
ToppCellfacs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ERBB4 POLE PKHD1L1 CNTN3 LGR6

1.22e-041621325bf886e22ff2a20353499004b53f25fb9e6574896
ToppCellfacs-Marrow-B-cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN SLC38A5 NXPE2 TEX14 CD163L1

1.33e-041651325361a605d8f833d9ec54b120480dce397da35f9c3
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

DNAH3 FMO4 SLC38A5 ANKMY1

1.36e-048813245582666aed9c1f465264f18898783872b662400d
ToppCell(05)_Ciliated-(1)_24hpi|(05)_Ciliated / shred by cell type and Timepoint

CWH43 ALS2 OVGP1 CD163L1

1.36e-0488132476959e7e3f6fae07c9881a29c28ba847be406694
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

DNAH3 FMO4 SLC38A5 ANKMY1

1.36e-048813245f774a85415d3cf163046f1154a82f749bf628fe
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

DNAH3 FMO4 SLC38A5 ANKMY1

1.36e-04881324f59eeaba4a3c5ef03f741ed6a31fe88f57651374
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CYP26B1 CHRNA3 XIRP2 GLCE PRKCA

1.36e-0416613256a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef
ToppCellBAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CERK ERN1 ZAP70 EEF1A1 KCNQ3

1.36e-041661325bb93db4613c067c56614ab1ca39e73ee46484387
ToppCellBAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CERK ERN1 ZAP70 EEF1A1 KCNQ3

1.36e-041661325c1f17a028bb27b8f202bcfffa7de7373b1cdd990
ToppCellPND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ERN1 TSEN54 RRM1 CSGALNACT2 SMG7

1.44e-04168132527cdf5cfa1d906868cfd60fdfab3cd51f3b3602f
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 ANGPT1 CHRNA3 EGFR IGSF3

1.44e-041681325f3879a8e11eaf866f37c52e67021be43f0b8784a
ToppCellNS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ERBB2 NXPE2 B3GNT6 EGFR FOXC2

1.48e-041691325aec97583b23112060437b619cb429dc32f29285f
ToppCellP15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LGR4 SLC38A5 CLCN7 SERGEF LGR6

1.52e-041701325ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCellCOVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

DMXL2 CD163 FOXD4L1 XIRP2 CD163L1

1.52e-0417013254232fe937909f93d3736988c707b8f95ce993398
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 ANGPT1 EGFR CBLN2 IGSF3

1.52e-04170132514aa86a4f526ed6986afcb28c49225522055550c
ToppCelldroplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZAP70 HDGFL3 EEF1A1 PRKCA CMAHP

1.52e-0417013258e9b5f7bfb61f8d84d0b17fb0c191da4dabad63d
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

POLE RCC1 PER2 PRDM6 WIPI2

1.52e-041701325b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 ANGPT1 EGFR CBLN2 IGSF3

1.57e-0417113255efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 CHRNA3 EGFR CBLN2 IGSF3

1.57e-041711325f9ae7964a3740f559431125c17c660549798cccc
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANGPT1 IL1RAPL1 LGR6 PRDM6 FOXC2

1.57e-0417113254ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 ANGPT1 EGFR CBLN2 IGSF3

1.61e-0417213257e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCelldroplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN SLC25A30 PKHD1L1 NECTIN2 FOXC2

1.65e-0417313259dc7746a84f0e268a7c061e1bbcd5e31903034dc
ToppCellIIH-CD8-naive_CD4|IIH / Condition, Cell_class and T cell subcluster

POLE SLC38A5 COX15 ANKMY1 CLCN7

1.65e-0417313254f2843371d18af766c1892529ce286f56c956fde
ToppCelldroplet-Marrow-nan-24m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPT1 ZAP70 HDGFL3 EEF1A1 PRKCA

1.70e-041741325955a3de6b7efc117f34c14faf8051f41454275dd
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 CHRNA3 EGFR CBLN2 IGSF3

1.70e-041741325a5f2a4e3b25e6084bd7003a53da86a44f6fcf294
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

DNAH3 MYO10 EGFR MTCL1 IGSF3

1.70e-041741325110369f6b78de34a6d934b5b47cecd023347bc80
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EEF1A2 XIRP2 ANKRD2 PXMP2 KCNQ3

1.70e-0417413254a6e04b4f12b87c15fa1409989cbe32c43736369
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPAG1 SLFN5 ZAP70 HDGFL3 TNFSF11

1.75e-041751325e219b61d6bc078d44ea7d06191d3462654d857a1
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPAG1 SLFN5 ZAP70 HDGFL3 TNFSF11

1.75e-041751325bd16c80418bf71127e6f1e50edf83967c9218b42
ToppCellP15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RELN RIPOR3 PKHD1L1 NECTIN2 TMEM200C

1.75e-04175132584d252f3e432231687613299bbea14978bb4b06b
ToppCelldroplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZAP70 HDGFL3 EEF1A1 PRKCA CMAHP

1.75e-041751325f949613ee45f5d950578c512d197716855118d18
ToppCellP15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RELN RIPOR3 PKHD1L1 NECTIN2 TMEM200C

1.75e-041751325a00c6fa9b33640710dd05a3799031147196f0986
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RBP4 RIPOR3 EGFR OLFM2 KDM1B

1.79e-04176132533323c97afe509147956b8df9f92ca6b0537e604
ToppCellControl-Lymphocyte-T_NK-CD8_TCM|Control / Disease, Lineage and Cell Type

RPL35A SLFN5 ZAP70 EEF1A1 PRKCA

1.79e-0417613251a7948eb86ee1da607db4d0576312b2859d94523
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 ANGPT1 EGFR CBLN2 IGSF3

1.79e-04176132505ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RPL35A ANGPT1 CWH43 EEF1A1 SULT1C3

1.79e-041761325b942227abf9902ba13fac6c3e9efb0cacc82af94
ToppCellfacs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN NXPE2 PKHD1L1 ANKRD2 NECTIN2

1.79e-041761325460cb302c5b3d609c65b924e1d4e8ea057a68485
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ERBB4 ANGPT1 EGFR NECTIN2 IGSF3

1.84e-04177132585e270b4a0b0da77ffe5987a099e827c02a4adf3
ToppCellP28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RELN RIPOR3 PKHD1L1 NECTIN2 TMEM200C

1.84e-0417713256e330aa3c87fd640526b746a9deb3b2250d2518c
ToppCellE12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RELN NHSL2 SLC25A30 PRDM6 FOXC2

1.84e-0417713255cdf413f82376a95467322b16d10b0d1e7557e2d
ToppCelldroplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC38A5 NXPE2 ZAP70 HDGFL3 CAMSAP2

1.84e-041771325650095a17e1a39caea74a6e89646565b9332af5d
ToppCellP28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RELN RIPOR3 PKHD1L1 NECTIN2 TMEM200C

1.84e-041771325e96a7e4544710aaab8bd2800ecff9667880a8bf4
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RPL35A ZAP70 EEF1A1 CD163L1 CMAHP

1.84e-04177132581511383b010ab744ebc622c180f926d469194c1
ToppCelldroplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC38A5 NXPE2 ZAP70 HDGFL3 CAMSAP2

1.84e-041771325d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RPL35A ZAP70 EEF1A1 CD163L1 CMAHP

1.89e-041781325934a2a7b35a23b56e34d4d0ef68c271513ef1fe9
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPL35A ZAP70 EEF1A1 PRKCA CMAHP

1.89e-041781325cd0c5f15e6b28ce2208346279ee9503d18d9b27d
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPL35A ZAP70 EEF1A1 PRKCA CMAHP

1.89e-041781325813d121a45e0416de1f26862851f6f0bda7ba43c
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ERBB4 ANGPT1 CBLN2 IGSF3

1.91e-0496132478f19fee755061b4144b1beebb60f4e8bc4dbf0d
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

RBP4 TNFSF11 EGFR CAMSAP2 FOXC2

1.94e-04179132598c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ERBB4 ARL9 EGFR IL1RAPL2

1.94e-041791325c7afbd10072d36a35cd20ae73670d76b9cefd22d
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RPL35A ZAP70 EEF1A1 CD163L1 CMAHP

1.94e-04179132520cac7b3035a2bb0b09f58741617550f1f623fc9
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RIPOR3 IL1RAPL1 EGFR CBLN2 PRDM6

1.94e-041791325a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCellmetastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass

RPL35A TSEN54 SLFN5 ZAP70 EEF1A1

1.99e-04180132516516dd9c78c27fc76f58d650de9851ffa0763e7
ToppCellIIH-CD8-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster

PECR ANKMY1 AAR2 XRN1 ZNF44

1.99e-041801325d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DNAH3 RELN ERBB4 EGFR IL1RAPL2

1.99e-041801325b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ERBB4 EGFR CD163L1 LGR6

2.04e-041811325062f00736eed96e4f4327615d093558dd7d82b20
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN PKHD1L1 NECTIN2 TMEM200C IGSF3

2.04e-041811325b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCellRV|World / Chamber and Cluster_Paper

DECR1 IL1RAPL1 PPP2R3A XIRP2 NAV1

2.04e-041811325bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN PKHD1L1 NECTIN2 TMEM200C IGSF3

2.04e-041811325cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RELN PKHD1L1 NECTIN2 TMEM200C IGSF3

2.04e-041811325ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RPL35A ZAP70 EEF1A1 CD163L1 CMAHP

2.09e-041821325c7e07570480295e1ad3c5fbbb16b8e4df90c690d
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ERBB4 ANGPT1 EGFR NECTIN2 IGSF3

2.09e-0418213253d7a8d2ee2137b098248597058974ef5ae09c19e
ToppCelldroplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPT1 ZAP70 HDGFL3 TET1 XRN1

2.09e-041821325e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCelldroplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPT1 ZAP70 HDGFL3 TET1 XRN1

2.09e-0418213251710eab3037a87609d21838be2d2d29c3bc36651
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ERBB4 EGFR CD163L1 LGR6

2.09e-041821325d3a037268f026eb2f84428b1821022503cef7756
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZAP70 HDGFL3 EEF1A1 PRKCA CMAHP

2.09e-0418213256339fc979aa097627924849f436bb9e9c14f4ce3
ToppCelldroplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EEF1A2 KCNC4 XIRP2 ANKRD2 PXMP2

2.09e-041821325edfc598b7199ca1d8a399b264ab863c299b1eede
Drugpyrido[3,4-d]pyrimidine

ERBB2 ERBB4 EGFR

1.78e-0731293CID014758064
DrugAndrogen Antagonists

ERBB2 RELN ERBB4 GRIA4 IL1RAPL1 CNTN3

4.30e-06751296ctd:D000726
Drugbut-2-enamide

ERBB2 DECR1 EGFR

1.46e-0591293CID000031877
Drugbenzylidenemalononitrile

ERBB2 ERBB4 DECR1 EGFR

1.56e-05271294CID000017608
DrugIopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A

CEL RBP4 PPP2R3A SULT1B1 EGFR SERGEF FOXG1 ZNF44

1.70e-0519712986842_UP
Drugraloxifene hydrochloride; Up 200; 0.1uM; HL60; HG-U133A

DNAH3 CHRNA3 CD163 HDGFL3 PPP2R3A PRKCA PAX1 BAIAP2

1.70e-051971298388_UP
DrugGBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; PC3; HT_HG-U133A

DNAH3 CWH43 SULT1B1 SMG7 IL1RAPL2 FOXG1 WIPI2 ZNF44

1.83e-0519912984641_DN
Drug6-(methylamino)pyrido(3,4-d)pyrimidine

ERBB2 ERBB4 EGFR

2.07e-05101293ctd:C107875
Drugcelecoxib

ERBB2 ANGPT1 CEL ALS2 TNFRSF10A SULT1B1 TNFSF11 EGFR FOXG1

2.63e-052731299CID000002662
DrugBE-23372M

ERBB2 ERBB4 EGFR

2.84e-05111293CID005311105
Drugprocymidone

ERBB2 RELN ERBB4 GRIA4 IL1RAPL1 SULT1B1 EGFR

2.95e-051551297ctd:C035988
DrugPrestwick_517

ERBB2 ERBB4 SLC38A5 EGFR GLCE PAX1

3.16e-051061296CID000003804
DrugN-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide

ERBB2 EGFR

3.19e-0521292ctd:C570404
Drugcarcinolipin

CEL EEF1A2

3.19e-0521292CID000159870
DrugLapatinib

ERBB2 EGFR

3.19e-0521292DB01259
Diseasedevelopmental and epileptic encephalopathy 33 (implicated_via_orthology)

EEF1A1 EEF1A1P5 EEF1A2

7.97e-0831283DOID:0080463 (implicated_via_orthology)
Diseasegallbladder neoplasm

ERBB2 ERBB4 EGFR

1.28e-05111283C0016978
DiseaseMalignant neoplasm of gallbladder

ERBB2 ERBB4 EGFR

1.28e-05111283C0153452
Diseasedilated cardiomyopathy (implicated_via_orthology)

ERBB2 EEF1A1 EEF1A1P5 EEF1A2 EGFR

2.63e-05801285DOID:12930 (implicated_via_orthology)
Diseasemedian neuropathy (biomarker_via_orthology)

ERBB2 ERBB4 EGFR

2.80e-05141283DOID:571 (biomarker_via_orthology)
Diseasediastolic blood pressure, systolic blood pressure

ANGPT1 TRPC4 KMT2E DNAH7 PXMP2 NAV1 PRKCA PRKCSH OLFM2 FTO CMAHP PRDM6

3.68e-0567012812EFO_0006335, EFO_0006336
DiseaseOsteopetrosis Autosomal Dominant Type 2

TNFSF11 CLCN7

5.59e-0531282C3179239
DiseaseCongenital Osteopetrosis

TNFSF11 CLCN7

5.59e-0531282C3645711
Diseaselung adenocarcinoma (is_implicated_in)

ERBB2 ERBB4 CHRNA3 EGFR

6.15e-05491284DOID:3910 (is_implicated_in)
DiseaseAdenocarcinoma of large intestine

ERBB2 ERBB4 POLE EGFR PRKCA

6.33e-05961285C1319315
Diseaselaryngeal squamous cell carcinoma (is_marker_for)

ERBB2 ERBB4 EGFR

7.34e-05191283DOID:2876 (is_marker_for)
DiseaseInfantile malignant osteopetrosis

TNFSF11 CLCN7

1.11e-0441282C1318518
Diseasetransitional cell carcinoma (is_marker_for)

ERBB2 ERBB4 ANGPT1 EGFR

1.65e-04631284DOID:2671 (is_marker_for)
Diseasekallikrein-7 measurement

CD163 CD163L1

1.85e-0451282EFO_0008195
DiseaseOsteopetrosis

TNFSF11 CLCN7

1.85e-0451282C0029454
DiseaseCetuximab response

ERBB2 EGFR

1.85e-0451282cv:CN077967
DiseasePanitumumab response

ERBB2 EGFR

1.85e-0451282cv:CN077999
Diseasesmoking behavior, body mass index

DMXL2 ERBB4 NXPE2 NAV1 FTO

2.04e-041231285EFO_0004318, EFO_0004340
Diseasealcohol use disorder (implicated_via_orthology)

ERBB2 ERBB4 ANGPT1 CHRNA3 EGFR PRKCA

2.14e-041951286DOID:1574 (implicated_via_orthology)
Diseaserenal cell carcinoma (is_marker_for)

ERBB2 ERBB4 ANGPT1 TNFRSF10A EGFR

2.45e-041281285DOID:4450 (is_marker_for)
Diseaseintestinal cancer (implicated_via_orthology)

ERBB2 ERBB4 EGFR

3.61e-04321283DOID:10155 (implicated_via_orthology)
Diseaseresponse to paliperidone, schizophrenia symptom severity measurement

PECR CWH43 CEL EPG5 CBLN2 PRKCSH

3.71e-042161286EFO_0007925, EFO_0007927
Diseaseabdominal aortic artery calcification

NECTIN2 NAV1

3.87e-0471282EFO_0004859
Diseaseliver cirrhosis (is_marker_for)

RELN RBP4 CD163 EGFR

4.55e-04821284DOID:5082 (is_marker_for)
Diseasehead and neck squamous cell carcinoma (is_marker_for)

ERBB2 ERBB4

5.14e-0481282DOID:5520 (is_marker_for)
Diseaseductal carcinoma in situ (is_marker_for)

ERBB2 ERBB4 PRKCA

6.50e-04391283DOID:0060074 (is_marker_for)
Diseaseautistic disorder (is_implicated_in)

RELN KMT2E KCNQ3

8.09e-04421283DOID:12849 (is_implicated_in)
DiseaseHead and Neck Carcinoma

ERBB2 EGFR

8.21e-04101282C3887461
DiseaseCognitive impairment

DMXL1 NECTIN2

1.00e-03111282HP_0100543
DiseasePapilloma

ERBB2 EGFR

1.20e-03121282C0030354
DiseasePapillomatosis

ERBB2 EGFR

1.20e-03121282C0205875
DiseasePapilloma, Squamous Cell

ERBB2 EGFR

1.20e-03121282C0205874
Diseaseurinary bladder cancer (is_marker_for)

ERBB2 ERBB4 EGFR PRKCA

1.23e-031071284DOID:11054 (is_marker_for)
DiseaseNeoplasm of lung

ERBB2 EGFR

1.64e-03141282cv:C0024121
DiseaseLung cancer

ERBB2 EGFR

1.64e-03141282cv:C0242379
DiseaseLUNG CANCER

ERBB2 EGFR

1.64e-03141282211980
Diseaseovarian cancer (is_implicated_in)

ERBB2 EEF1A2 PRKCA

1.87e-03561283DOID:2394 (is_implicated_in)
DiseaseStomach Neoplasms

ERBB2 POLE RBP4 EEF1A1 EEF1A2 EGFR

1.92e-032971286C0038356
Diseasecolorectal cancer (is_implicated_in)

ERBB4 POLE YTHDF1 EGFR

1.94e-031211284DOID:9256 (is_implicated_in)
DiseaseMalignant neoplasm of stomach

ERBB2 POLE RBP4 EEF1A1 EEF1A2 EGFR

2.02e-033001286C0024623
Diseaseurate measurement, spine bone mineral density

EGFR PRDM6 RIC1

2.07e-03581283EFO_0004531, EFO_0007701
DiseaseBenign neoplasm of stomach

ERBB2 POLE

2.43e-03171282C0153943
DiseaseNeoplasm of uncertain or unknown behavior of stomach

ERBB2 POLE

2.43e-03171282C0496905
DiseaseAntibody Deficiency Syndrome

ZAP70 EPG5

2.43e-03171282C0003257
DiseaseCarcinoma in situ of stomach

ERBB2 POLE

2.43e-03171282C0154060
Diseaseoral squamous cell carcinoma (is_marker_for)

ERBB2 ERBB4 EGFR

2.62e-03631283DOID:0050866 (is_marker_for)
DiseaseAdrenocortical carcinoma

RRM1 EGFR

2.73e-03181282C0206686
DiseaseMalignant neoplasm of endometrium

POLE EGFR

2.73e-03181282C0007103
DiseaseCarcinoma in situ of endometrium

POLE EGFR

2.73e-03181282C0346191
Diseasecarcinoma (implicated_via_orthology)

ERBB2 ERBB4 EGFR

2.74e-03641283DOID:305 (implicated_via_orthology)
Diseasefacial asymmetry measurement

CNBD1 MYO10

3.04e-03191282EFO_0009751
Diseaseinterstitial lung disease

SPAG1 CWH43 NAV1

3.12e-03671283EFO_0004244
Diseasecortical thickness

CNBD1 RELN ANGPT1 LGR4 GLOD4 HDGFL3 TNFSF11 SMG7 EGFR NAV1 MTCL1 FOXC2

3.36e-03111312812EFO_0004840
Diseaserenal cell carcinoma (is_implicated_in)

ERBB2 TNFRSF10A FTO

3.39e-03691283DOID:4450 (is_implicated_in)
DiseaseAnimal Mammary Neoplasms

ERBB2 RBP4 EEF1A1 EGFR

3.46e-031421284C0024667
DiseaseMammary Carcinoma, Animal

ERBB2 RBP4 EEF1A1 EGFR

3.46e-031421284C1257925
Diseasecardiomyopathy (implicated_via_orthology)

ERBB2 ERBB4 EGFR

3.68e-03711283DOID:0050700 (implicated_via_orthology)
Diseasebone density, lean body mass

TNFSF11 FTO

3.71e-03211282EFO_0003923, EFO_0004995
DiseaseStomach Carcinoma

ERBB2 POLE

3.71e-03211282C0699791
Diseaseglioma

GRIA4 EGFR

4.07e-03221282EFO_0005543
Diseaselung cancer (is_implicated_in)

POLE TRPC4 CHRNA3

4.13e-03741283DOID:1324 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
TVWELMTFGAKPYDG

ERBB2

911

P04626
YGVTIWELMTFGGKP

ERBB4

906

Q15303
FKSFGLFSKWSPYMA

EPG5

1911

Q9HCE0
LKWNPSDYGGAEFMR

CHRNA3

96

P32297
YTLGFWKTFPGKMTD

ALS2

891

Q96Q42
MGATAGWAVTVYDKP

ALG1L2

1

C9J202
YNSWEVGPKFRGVKM

AAR2

36

Q9Y312
GGSKPFRSYWEMYLS

ARL9

71

Q6T311
PTGWSSESYGLSKMA

ADAD1

36

Q96M93
GEGFKSLEPGWYSAM

GLCE

431

O94923
WKEYKMGFGNPSGEY

ANGPT1

341

Q15389
TGFSWRKTSKYMPRG

DMXL2

236

Q8TDJ6
FGMTYFKEASGPIWL

CD163L1

526

Q9NR16
AYWTNFAKTGDPNMG

CEL

486

P19835
GFSWRKTSKYMPRAS

DMXL1

236

Q9Y485
WRYMGGFAKSVSFSD

NDUFB3

51

O43676
YTDKDNGGMLVWSPY

RCOR3

21

Q9P2K3
TKDGRVFAWGMGTNY

RCC1

361

P18754
WDTGYPKRSAGEAFM

OLFM2

361

O95897
FGSYKQAEWRPDSTM

RIC1

66

Q4ADV7
PGMAQKGYSESAWAR

MTCL1

1731

Q9Y4B5
KARFSMPGDNEGLWY

ACP7

216

Q6ZNF0
AYMPKAAGSWVAGST

OR13C7

141

P0DN81
KGWAPTFLGYSMQGL

SLC25A3

121

Q00325
EGLKAFYKGVAPLWM

SLC25A3

211

Q00325
GTSGKPALEDLYWMS

MAFA

106

Q8NHW3
ETLEYKMSWFGSKPA

GOLGA1

736

Q92805
PYGMCASFFKASGQW

LGR6

481

Q9HBX8
SKPYDGKWSKTMVGF

GLOD4

61

Q9HC38
KEEPYFGMGKMAVSW

FTO

216

Q9C0B1
SWIGPDHDKFSAMKY

PRKCSH

451

P14314
LDGFQIPKGWSVMYS

CYP26B1

381

Q9NR63
YVFGPNGGSSWMREK

KCNQ3

816

O43525
TGAAIWADPGKYALM

CLCN7

536

P51798
STGPRKVGYWNDMDK

GRIA4

381

P48058
GLTFMDRAGSLYWPM

FOXG1

296

P55316
YKLPLWSMCSGADSF

PER2

246

O15055
GLSLMWYKSSGPGDF

IL1RAPL1

71

Q9NZN1
FGYSGDVSPLIYWMK

IL1RAPL1

271

Q9NZN1
MASWAKGRSYLAPGL

PECR

1

Q9BY49
SKPASMSHYLKAWGA

FMO4

506

P31512
AKYMALIKEWPGYGS

MYO10

1941

Q9HD67
NFATPRWIDYGKMAS

KDM4E

291

B2RXH2
GTMYSSWVKSPDRTG

KMT2E

1061

Q8IZD2
TGAFKPCEYLLGSWM

LGR4

526

Q9BXB1
GKGSYWTLDPDSYNM

FOXC2

141

Q99958
PVSYFSQKGAWMDLS

JRKL

246

Q9Y4A0
YWLFGSQMGKPVSFS

LHFPL1

31

Q86WI0
WMDPSNYGGIKGKVS

POLE

1916

Q07864
WMGLDCGPESSKKYA

PGK1

311

P00558
AGDLVFAKMKGYPHW

HDGFL3

11

Q9Y3E1
YWKAPMFRAAGGEKT

PPP2R3A

761

Q06190
DAGMSWFLVKEGCYP

RELN

1326

P78509
FIDGGEPSKSSWMRY

PRDM6

311

Q9NQX0
SEGTAYSPKMEDWAG

PAX1

311

P15863
SKSLAAEWGKYGMRF

DECR1

221

Q16698
GVTVWELMTFGSKPY

EGFR

901

P00533
MAKAPSWAGVGALAY

ANKRD2

1

Q9GZV1
KKDSGFWRDFGFGMT

CSGALNACT2

421

Q8N6G5
SPSGMWYKRAEDTAG

IGSF3

926

O75054
PWIQMAYSFVKTGGS

KDM1B

761

Q8NB78
MSALNWKPFVYGGLA

SLC25A30

1

Q5SVS4
PSGSGKMIEDYWGVS

DNAH3

2816

Q8TD57
MSGEVGRITKWKYPF

ERN1

256

O75460
GSGKWQKMEKPYAFT

CERK

71

Q8TCT0
AAEMGKGSFKYAWVL

EEF1A2

46

Q05639
AAEMGKGSFKYAWVL

EEF1A1

46

P68104
DMIFYGFLKPWLGDG

CYP4F11

121

Q9HBI6
WMGKSYPSLKPLGSY

DNAH7

3836

Q8WXX0
NLMGGWKYSTFSGFL

CBLN2

206

Q8IUK8
FGLNMKLGYGKFSWP

ANKMY1

6

Q9P2S6
YTPMKGGISNVWFDR

LYPLAL1

66

Q5VWZ2
AAEMGKGSFKYAWVL

EEF1A1P5

46

Q5VTE0
GKGTYWSLDPASQDM

FOXD4L1

176

Q9NU39
AGLVYNSFPKMGESW

COX15

286

Q7KZN9
MEGSVPIRDSWSKYF

B3GNT6

251

Q6ZMB0
VFYNGAWGTVGKSSM

CD163

841

Q86VB7
RAVAAATYKTMGPAW

SART3

41

Q15020
SMSYVDGFIGTWPKE

CAMSAP2

416

Q08AD1
RYWNGGGKEESSSKM

CNTN3

841

Q9P232
VMKSWSTGYPKRSAG

OLFM3

381

Q96PB7
PKSSAYAMNYWRKLG

OVGP1

236

Q12889
YDSGSLKMEPGTSKW

NAV1

486

Q8NEY1
MWLGEKLGFYTDFGP

CWH43

481

Q9H720
MSGRLWSKAIFAGYK

RPL35A

1

P18077
TETGKMFTWGRADYG

SERGEF

281

Q9UGK8
RKGMPGDWKNYFTVA

SULT1C3

266

Q6IMI6
GKAMPWFQFYLTGAT

TEX14

211

Q8IWB6
LKSPAGKFWQTMGFS

TSEN54

91

Q7Z6J9
DAFGAAAMLAKGSWP

TMEM200C

271

A6NKL6
FGVSELMKMPASGWY

PRKCA

261

P17252
SWKGDAFTYMTPSAT

NHSL2

391

Q5HYW2
FPSGYTLKKMWITAF

NXPE2

326

Q96DL1
GYMTQFPTFPSWLGK

RFC1

951

P35251
SAMPWGDPSYKSANF

RNF166

186

Q96A37
TFLYMDPEGDWFLKG

SLC38A5

156

Q8WUX1
FSGESGPMIYWMKGE

IL1RAPL2

271

Q9NP60
WKTDKPAMGGFGIDY

SMG7

1046

Q92540
ENFKLKHYGPGWVSM

PPIB

126

P23284
EEPTTWTGYFGKVLM

WIPI2

286

Q9Y4P8
FMRKGTAGDWKNYFT

SULT1B1

256

O43704
MGSPLGHFTWDKYLK

SCMH1

21

Q96GD3
WSMYFNGCKFGRSPS

TET1

1581

Q8NFU7
GVWSMPSKYSEEGVY

ABHD10

201

Q9NUJ1
GESEKTKMRGWFPFS

BAIAP2

416

Q9UQB8
PMTFSGGKFTEEWKA

CMAHP

211

Q9Y471
WFYIDFGGVKPMGSE

SLC25A13

606

Q9UJS0
LPSYDSMLSKWSTFG

CNBD1

251

Q8NA66
VYMGHGGKPWVSDFS

CNDP2

376

Q96KP4
GGDVKYTTWMFETQP

XIRP2

436

A4UGR9
MSGLNWKPFVYGGLA

SLC25A14

36

O95258
GVTMWEALSYGQKPY

ZAP70

526

P43403
DASAFAAKMRGGFWP

PXMP2

136

Q9NR77
KFSMGSRKGSLYNWT

RIPOR3

331

Q96MK2
TSMHFYGWKQGLKTG

RRM1

721

P23921
KGMNFTWKTYNPAFS

TMEM181

296

Q9P2C4
ARFSGTWYAMAKKDP

RBP4

36

P02753
MTTKDYPSLWGFGTT

SPAG1

1

Q07617
VPGYTKKVGSEWMYS

XRN1

966

Q8IZH2
PSGAYFAWKATAMGK

PSMA2

151

P25787
WKAFTKMASAPASYG

SCFD1

496

Q8WVM8
YNEKTPGYMGASWVD

PKHD1L1

361

Q86WI1
TAGPGDALYAMLMKW

TNFRSF10A

401

O00220
MKGGSTKYWSGNSEF

TNFSF11

256

O14788
FTAWYSDMETPLKAG

TRIM16

476

O95361
GTFWGYPKMLEAANL

ZNF44

6

P15621
FSKWDAGCKGYSMIV

SLFN5

456

Q08AF3
GTIGAVAAWLMSYKP

TEX46

11

H3BTG2
TFPKMLYCNWTGGYK

TM2D3

171

Q9BRN9
KLWMSYFEEGGTLPT

TRPC4

641

Q9UBN4
EMKSPVDYGTSAGVW

YTHDF1

451

Q9BYJ9
TLGYGDMYPKTWSGM

KCNC4

436

Q03721
FYMLKGSWEAGNPSC

NLRP14

491

Q86W24
EFATFPKGSVRGMTW

NECTIN2

141

Q92692